| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.099 | 0.1 |